Table 2 Correlation between clinicopathological features and LPCAT1 expression in ccRCC patients

Age (year)

  < 60

47 (54.02%)

35 (40.23%)

5 (5.75%)

0.122^b

 60 ≤ age ≤ 70

15 (35.71%)

18 (42.86%)

9 (21.43%)

  > 70

11 (52.38%)

7 (33.33%)

3 (14.29%)

Gender

0.860^a

 Male

52 (48.60%)

42 (39.25%)

13 (12.15%)

 Female

21 (48.84%)

18 (41.86%)

4 (9.30%)

Grade

<.0001^b

 1

48 (77.42%)

12 (19.35%)

2 (3.23%)

 2

22 (31.88%)

42 (60.87%)

5 (7.25%)

 3–4

3 (15.79%)

6 (31.58%)

10 (52.63%)

Stage

0.046^b

 1

65 (53.28%)

46 (37.70%)

11 (9.02%)

 2

3 (18.75%)

9 (56.25%)

4 (25.00%)

 3–4

5 (41.67%)

5 (41.67%)

2 (16.66%)

Diameter

0.003^b

  ≤ 4

41 (54.67%)

29 (38.67%)

5 (6.66%)

 4 < Diameter ≤ 7

28 (52.83%)

19 (35.85%)

6 (11.32%)

 Diameter > 7

4 (18.18%)

12 (54.55%)

6 (27.27%)